Navigation Links
Large Controlled Trial of Widely Used Mood Stabilizers Demonstrates Efficacy in Pediatric Bipolar Disorder
Date:10/26/2007

Shows Treatment Significantly Effective at Eight Weeks

CINCINNATI, Oct. 26 /PRNewswire/ -- In the largest pediatric study of its kind on mood stabilizers, scientists from Cincinnati Children's Hospital Medical Center and two other centers demonstrated that divalproex sodium (Depakote(R)) has efficacy for significantly improving symptoms of bipolar I disorder in children and adolescents, according to results presented today at the annual meeting of the American Academy of Child and Adolescent Psychiatry in Boston.

Many psychiatric medications prescribed for children and adolescents have not been indicated by the FDA for pediatric use. Making sure these drugs are effective and safe has been an important goal of pediatric psychiatry researchers as well as gaining FDA indications for appropriate use in children.

"Divalproex and lithium are the most widely used mood stabilizers for children and adolescents diagnosed with bipolar disorder," said Robert A. Kowatch, M.D., Ph.D., a child and adolescent psychiatrist specializing in bipolar and other mood disorders at Cincinnati Children's. "Our study now proves that these agents definitely work, which may give clinicians and families peace of mind."

Dr. Kowatch presented the eight-week, acute efficacy results from the Pediatric Bipolar Collaborative Mood Stabilizer Trial, which also included a second, 16-week phase. The investigation is the first controlled trial to test and compare lithium and divalproex versus placebo for six months, the largest trial of lithium and divalproex to date and first to demonstrate efficacy for divalproex in children aged 7 to 17 years, diagnosed with bipolar I disorder, mixed or manic, based on standardized criteria.

Specifically, at the end of an eight-week treatment phase, patients receiving divalproex significantly decreased their average scores (p<0.01 compared to placebo) on the study's primary outcome measure for manic symptom severity, the Youn
'/>"/>

SOURCE Cincinnati Children's Hospital Medical Center
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Urinalysis Analyzers: Large Capabilities in Every Size Device
2. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
3. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
4. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
5. Largest National U.S. Healthcare Facility MRSA Study Reveals Infection Rates Eight Times Greater Than Previous Estimates
6. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
7. MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
8. First Controlled Large-Scale Intervention Angiotensin Receptor Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study Demonstrates Significant Reduction in Blood Pressure and Protection of Organs with Valsartan
9. Large Study Shows that Presence of Neutralizing Antibodies Did Not Predict Clinical Response to Betaseron Treatment
10. Medical Journal Publishes First Large-Scale Survey Revealing Experiences of IPF Patients
11. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... Columbia and MENLO PARK, ... DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" ... developing and commercializing proven cancer therapies in new ... from its Phase I/II clinical trial of  VAL-083 ... the most common and deadly form of human ...
(Date:6/1/2015)... LONDON , June 1, 2015 ... carcinoma segment will drive growth , says   ... Cell Lung Cancer (NSCLC) treatment market will be driven primarily ... and squamous cell treatment settings, which either replace or combine ... GBI Research - Non-Small Cell Lung Cancer Market to ...
(Date:6/1/2015)... DUBLIN , May 29, 2015 ... the addition of the "Global Power Wheelchair ... The Global Power Wheelchair Industry Report ... the current state of the power wheelchair industry. ... of the industry including definitions, classifications, applications and ...
Breaking Medicine Technology:DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 2DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 4DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 5DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 6DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 7DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 8New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 2New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 3Global Power Wheelchair Industry Trends 2015-2020 2
... 2011 Alere Inc. (NYSE: ALR ), ... health at home through the merger of rapid diagnostics and health ... 31, 2010. Financial results for the fourth quarter ... the fourth quarter of 2010, compared to $546.2 million for the ...
... 2011 Cepheid (Nasdaq: CPHD ) today ... following investor conferences, and invited investors to participate via ... 1, 2011 at 8.30 a.m. Eastern TimeRBC Capital Markets, ... 11.00 a.m. Eastern TimeTo access the live webcasts for ...
Cached Medicine Technology:Alere Inc. Announces Fourth Quarter 2010 Results 2Alere Inc. Announces Fourth Quarter 2010 Results 3Alere Inc. Announces Fourth Quarter 2010 Results 4Alere Inc. Announces Fourth Quarter 2010 Results 5Alere Inc. Announces Fourth Quarter 2010 Results 6Alere Inc. Announces Fourth Quarter 2010 Results 7Alere Inc. Announces Fourth Quarter 2010 Results 8Alere Inc. Announces Fourth Quarter 2010 Results 9Alere Inc. Announces Fourth Quarter 2010 Results 10Alere Inc. Announces Fourth Quarter 2010 Results 11Alere Inc. Announces Fourth Quarter 2010 Results 12Alere Inc. Announces Fourth Quarter 2010 Results 13Alere Inc. Announces Fourth Quarter 2010 Results 14Alere Inc. Announces Fourth Quarter 2010 Results 15Alere Inc. Announces Fourth Quarter 2010 Results 16Alere Inc. Announces Fourth Quarter 2010 Results 17Alere Inc. Announces Fourth Quarter 2010 Results 18Alere Inc. Announces Fourth Quarter 2010 Results 19Cepheid to Webcast Upcoming Financial Presentations 2
(Date:6/2/2015)... 02, 2015 Join us for a new ... in Honor of Rhonda Martin , who overcame her brain ... dedicated their resources to raising awareness and funds for brain ... awareness in hopes that there will be one less case ... welcome and encouraged to join the 1st Anniversary Awareness ...
(Date:6/2/2015)... 2015 Pacifica Graduate Institute ... by current and former students to honor the memory ... from 2002 until his death in 2013. His students ... of feeling, as well as his passion for politics, ... an analyst, teacher, and writer were felt in his ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 “We want men ... ultraviolet (UV) sun rays”, states Marta Phillips, owner of SunGrubbies.com, ... men’s sun hats and sun accessories that work well for ... not immediately evident. Sometimes sun damage can take up to ... neck are prime areas for skin cancer to occur. ...
(Date:6/1/2015)... (PRWEB) June 02, 2015 The ... Lynn Lester as a 2015-2016 inductee into its ... with this prestigious distinction for leadership in business. NAPW ... women, boasting more than 700,000 members and over 200 ... Lester with this prestigious award,” said NAPW President Star ...
(Date:6/1/2015)... June 02, 2015 The National ... Ditmyer as a 2015-2016 inductee into the NAPW ... recognized with this prestigious distinction for leadership in academics. ... Local Chapters, NAPW is the nation’s leading networking organization ... Marcia with this important distinction,” said NAPW President Star ...
Breaking Medicine News(10 mins):Health News:New Awareness Raising Event in Westwood, NJ to Benefit Renowned Brain Aneurysm Foundation 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 3Health News:It is Time to Show Father Who Knows Best, Says SunGrubbies.com, a Leading Online Sun Protection Retailer 2Health News:National Association of Professional Women Inducts Lynn Lester, Director of Clinical Operations/CEO, Recovery Treatment Center, Into its VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Marcia Ditmyer, Vice President of Academy for Academic Leadership, Into its VIP Professional Woman of the Year Circle 2
... Researchers from Japan have recently demonstrated the first evidence ... ,Fungal secondary metabolites such as gliotoxin, an ... Aspergillus//, possess immunosuppressive activities and have been thought to ... humans. ,Mast cells play a key role ...
... who are prone to backaches, insomnia and eyesight problems ... treatment protocol for treating software professionals would be outlined ... Thrissur next month, said eminent ayurveda expert Neelakantan Mooss ... Thaikkattu Mooss Vaidyaratnam Oushadhasala, said detailed examinations had been ...
... from National Cancer Institute, US is to start testing their ... drug metabolize, enzyme kinetics and drug action mechanisms in dogs ... ,Dr. Chand Khanna, Veterinary Oncologist said, “It turns out that ... represented in dogs and the dogs will help us prioritize ...
... new research conducted in Helsinki, Finland, gluten-free diet ... adolescents with coeliac disease.,Coeliac disease in adolescents has ... and disruptive behavioural disorders, particularly in the phase ... 9 adolescents with coeliac disease, aged 12 to ...
... the first of its kind, French researchers report of ... with attention-deficit/hyperactivity disorder//. , The authors, ... present the case report of a 3-year-old child, who ... and sleep problems. ,According to the parents, ...
... is expected to get a major boost with the central ... in the interior regions//. ,Health Minister Anbumani ... northeastern states in Assam's main city of Guwahati with a ... adequate nursing staff. ,"We shall make it mandatory for ...
Cached Medicine News:Health News:Gluten-Free Diet May Alleviate Psychiatric Symptoms In Adolescents 2Health News:Iron Supplementation Aid In Relief From Attention-Deficit/Hyperactivity Disorder 2
... ACL 8000 is an easy-to-use, automated system ... array of assays for managing hemostatic disordersincluding ... S. Also offers reflex and rerun testing ... it's backed by our high-quality service to ...
... System is designed to provide excellent capture ... carotid stenting interventions. The ACCUNET is a ... utilizes rapid exchange technology so that the ... catheter manipulations. It is available in both ...
Four disposable disc electrodes are pre-gelled and attached to wires in red, blue, black and green. 4mil carbon film, Ag/AgCl coated. Each package contains 20 individually sealed sets of four leads....
Lancet cut ultra sharp tip for low penetration resistance. Low noise and impedance level giving you a clear and reliable signal. Stainless steel needle, color coded attached lead wires. Needles sold ...
Medicine Products: